+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Melanoma Drug"

Metastatic Uveal Melanoma (MUM) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Metastatic Uveal Melanoma (MUM) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
US Melanoma Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Melanoma Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
From
Melanoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Melanoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 3809 Pages
  • Global
From
United Arab Emirates Melanoma Drug Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032 - Product Thumbnail Image

United Arab Emirates Melanoma Drug Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032

  • Report
  • April 2024
  • 80 Pages
  • United Arab Emirates United Arab Emirates
From
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator

The Melanoma Drug market is a subset of the larger Skin Cancer Drugs market. It is composed of drugs used to treat melanoma, a type of skin cancer. These drugs are typically used in combination with other treatments such as surgery, radiation, and immunotherapy. Commonly used drugs include targeted therapies, immunotherapies, and chemotherapy. Targeted therapies are designed to target specific molecules in the cancer cells, while immunotherapies are designed to boost the body's own immune system to fight the cancer. Chemotherapy is used to kill cancer cells. The Melanoma Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Bristol-Myers Squibb, Merck, Roche, Novartis, and Pfizer. Other companies include AstraZeneca, Eli Lilly, and GlaxoSmithKline. Show Less Read more